According to Future Market Insights, the global digital therapeutics market is expected to reach US$ 4.8 billion in 2022, with sales increasing at a 24.4% CAGR during the forecast period. By 2032, the market will be worth $42.5 billion USD.

IT companies are developing and acquiring digital therapies in order to infiltrate and disrupt the healthcare sector. Players are looking into whether digital medicines can improve quality of life and outcomes while keeping or lowering total healthcare costs in specific disease areas, as well as how patient data obtained through such products can be used to determine coverage. Startups are developing innovative digital therapeutic ideas in order to attract investors.

Off-patent compounds are being combined with medical devices further up the innovation spectrum, such as changing the mode of administration with better inhalers and auto-injectors. This necessitates increased investment in R&D as well as increased use of collaboration between molecule producers and device manufacturers.

Mass-market platforms offer a significant opportunity for large-scale interaction. Manufacturers of consumer electronics, specifically smartphones and smartwatches, have integrated healthcare services and encouraged third-party developers to create apps to improve patient outcomes.

Simultaneously, efforts to improve the quality of available apps have been made, with major app stores enforcing certain quality criteria. This is a positive development because it is critical to prioritise the safe storage of research-grade data.

Because of the aforementioned factors, the digital therapeutics market will expand at a rapid pace during the assessment period.

Key Players:

  • Teladoc Health, Inc.
  • Click Therapeutics, Inc.
  • Welldoc
  • DarioHealth Corp
  • BigHealth
  • Orexo AB
  • Akili Interactive Labs, Inc.
  • Freespira
  • Voluntis
  • Kaia Health
  • Kaiku Health
  • Theranica Bio-Electronics Ltd.
  • Propeller Health
  • Orexo US, Inc.
  • TALi Digital Limited
  • Limbix Health, Inc.

Read More@

Key Market Segments Covered in Digital Therapeutics Industry Research

By Solution:

  • Monotherapy
  • Combination Therapy

By Application:

  • Prevention
  • Management
  • Treatment

By Indication:

  • Diabetes
  • Obesity
  • Gastrointestinal Disorders
  • Cardiovascular Disease
  • Central Nervous Systems
  • Others

By Business Model:

  • Direct to consumer
  • Fee-for-service